Michael Catelani

Track

Insider profile

Currently holds a position at Anixa Biosciences Inc

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 54% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer, Chief Operating Officer, IR Contact Officer Anixa Biosciences Inc July 6, 2017 -
Michael Catelani's trades of Anixa Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
495.58
Quantity 48,250 -49.9%
Value US$1,098,559
Transaction date
Purchase
Price
405.74
Quantity 75,828 +49.4%
Value US$3,460,123
Transaction date
Purchase
Price
284.64
Quantity 73,846 -38.1%
Value US$4,921,215
Transaction date
Purchase
Price
2.66
Quantity 5,500 +43.5%
Value US$14,630
Transaction date
Purchase
Price
2.53
Quantity 2,509 +24.8%
Value US$6,348
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-15 2025-01-15
B Purchase
48,250 -49.9%
495.58
US$1,098,559 		48,250 -49.9% 495.58 US$1,098,559
2024-06-07 2024-06-07
B Purchase
75,828 +49.4%
405.74
US$3,460,123 		75,828 +49.4% 405.74 US$3,460,123
2023-07-21 2023-07-20
B Purchase
73,846 -38.1%
284.64
US$4,921,215 		73,846 -38.1% 284.64 US$4,921,215
2022-04-22 2022-04-21
B Purchase
5,500 +43.5%
2.66
US$14,630 		5,500 +43.5% 2.66 US$14,630
2022-04-21 2022-04-20
B Purchase
2,509 +24.8%
2.53
US$6,348 		2,509 +24.8% 2.53 US$6,348